购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Histone Demethylase
    (2)
  • Others
    (3)
TargetMol | Tags 通过 货期 筛选
  • 6-8周
    (1)
  • 8-10周
    (2)
  • 10-14周
    (1)
筛选
搜索结果
TargetMol产品目录中 "

lsd1 in 5

"的结果
  • 抑制剂&激动剂
    6
    TargetMol | Inhibitors_Agonists
  • LSD1-IN-5
    T118802035912-55-9
    LSD1-IN-5 increases dimethylated Lys4 of histone H3, shows no effect on expression of LSD1. LSD1-IN-5 is a potent and reversible inhibitor of lysine-specific demethylase 1 (LSD1), with an IC50 of 121 nM.
    • ¥ 10600
    6-8周
    规格
    数量
  • CBB1007 trihydrochloride
    T72244
    CBB1007三盐酸盐是 LSD1选择性抑制剂,IC50值为5.27uM。
    • ¥ 15000
    8-10周
    规格
    数量
  • Geranylgeranoic Acid
    T3666883807-40-3
    Geranylgeranoic acid (GGA) is an isoprenoid that has been found inS. chinensisand has anticancer activity.1It induces apoptosis in Huh7 and PLC/PRF/5 human hepatoma cells and MLE-10 transformed mouse hepatocytes, but not primary mouse hepatocytes, when used at concentrations ranging from 1 to 20 μM. GGA (10 μM) induces apoptosis in Huh7 cellsvialoss of the mitochondrial membrane potential and activation of interleukin-1β-converting enzyme (ICE) and cysteine protease precursor 32 (CPP32).2It also inhibits lysine-specific demethylase 1 (LSD1; IC50= 46.97 μM).3 1.Shidoji, Y., and Ogawa, H.Natural occurrence of cancer-preventive geranylgeranoic acid in medicinal herbsJ. Lipid Res.45(6)1092-1103(2004) 2.Shidoji, Y., Nakamura, N., Moriwaki, H., et al.Rapid loss in the mitochondrial membrane potential during geranylgeranoic acid-induced apoptosisBiochem. Biophys. Res. Commun.230(1)58-63(1997) 3.Sakane, C., Okitsu, T., Wada, A., et al.Inhibition of lysine-specific demethylase 1 by the acyclic diterpenoid geranylgeranoic acid and its derivativesBiochem. Biophys. Res. Commun.444(1)24-29(2014)
    • ¥ 2213
    期货
    规格
    数量
  • CBB1007 hydrochloride
    T723882070014-96-7
    CBB1007 hydrochloride,一种可逆的、选择性的高效组蛋白去甲基化酶LSD1的底物竞争性抑制剂,其对hLSD1的IC50值为5.27 uM。
    • ¥ 5370
    8-10周
    规格
    数量
  • lsd1/hdac6-in-2
    T891342982787-50-6
    LSD1 HDAC6-IN-2 (JBI-802) 是一种有效的口服LSD1 HDAC6 MAO-A抑制剂,具有IC50值为5 nM, 11 nM, 5 nM.该化合物能够有效抑制多发性骨髓瘤细胞株MM.1S、MM.1R和RPMI-8226的生长,并可用于急性髓系白血病和淋巴瘤等相关疾病的研究.
    • 待询
    10-14周
    规格
    数量
  • LSD1-IN-38
    T204124
    LSD1-IN-38 (Compound 23e) 是一种具有口服活性的可逆性赖氨酸特异性脱甲基酶 1 (LSD1) 抑制剂,IC50为 1.2 nM。该化合物能有效抑制癌细胞MV4-11、Kasumi-1和NCI-H526的增殖,其IC50分别为5 nM、4 nM和11 nM。LSD1-IN-38 还能够激活CD86的表达,EC50为0.034 μM,促进MV4-11细胞分化。在小鼠模型中,LSD1-IN-38 展示了明显的抗肿瘤活性。
    • 待询
    规格
    数量